发明名称 USE OF SNS-595 FOR TREATMENT OF A SUBJECT HAVING CANCER WITH BRCA2 MUTATION
摘要 Methods of using SNS-595 for treatment of a subject having cancer with BRCA2 mutation are described. In certain embodiments, the methods comprise administering a therapeutically effective amount of SNS-595 to a subject in need thereof.
申请公布号 UA103917(C2) 申请公布日期 2013.12.10
申请号 UA20110011392 申请日期 2010.03.01
申请人 SUNESIS PHARMACEUTECALS, INC. 发明人 HAWTIN, RACHAEL, E.;FOX, JUDITH, A.
分类号 A61K31/045;A61K31/4375;A61K45/06 主分类号 A61K31/045
代理机构 代理人
主权项
地址